Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Tommy's

UK company 03266897, incorporated on 22 October 1996.

Together, for every baby - Charity for Babies | Tommy's

Tommy's is the largest UK pregnancy and baby loss charity, funding research into stillbirth, premature birth and miscarriage and providing trusted pregnancy and baby loss information and support.

Company number
03266897
Incorporated
22 Oct 1996
Companies House status
Active

Company identity

Founded / incorporated
22 October 1996

Company number 03266897

Verify at Companies House
Legal name
TOMMY'S
Company type
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Region
London
Registered address
NICHOLAS HOUSE
3 LAURENCE POUNTNEY HILL
LONDON
EC4R 0BB
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

Tommy's
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

16 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

22 Jun
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUyNzUzODA2NmFkaXF6a2N4

Published 22 Jun 2026 09:58

02 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

22 Oct
1996

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2022
Funded years
2022
Age at first award
26 years

Projects

2022 EU-Funded Lead participant

Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes

1 Nov 2022 to 31 Oct 2026

Awarded
£70,022
Total cost £70,022

HappyMums is designed to improve our understanding on the biological mechanisms underlying the development of depressive symptoms in pregnancy, and the efficacy of interventions. It will interrogate a large collection of cohorts with multiple biological, medical, clinical, socio-demographic and environmental and lifestyle data to identify the most robust ...

Product types

EU-Funded